ARETHUSA
Phase 2 Completed
107 enrolled 14 charts
SIGNAL 2
Phase NA Completed
139 enrolled
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Phase 2 Completed
67 enrolled 15 charts
Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC
Phase NA Completed
200 enrolled
ISNA-Sein
Phase NA Completed
16 enrolled 2 charts
Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer
Phase 1 Completed
26 enrolled
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma
Phase 2 Completed
9 enrolled
Neo-CRAG
Phase 3 Completed
620 enrolled
BoBCaT
Completed
293 enrolled
SAKK 06/17
Phase 2 Completed
61 enrolled
IP4-CHRONOS
Phase NA Completed
100 enrolled 23 charts
POROMS
Completed
30,000 enrolled
ADAPT
Phase 2/3 Completed
4,936 enrolled
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
Phase 2 Completed
31 enrolled 8 charts
ESCC
Phase 3 Completed
254 enrolled
Neo-DRATEC
Phase NA Completed
147 enrolled
CAP with NAT
Completed
462 enrolled
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
Phase NA Completed
160 enrolled
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
Completed
218 enrolled
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Phase NA Completed
57 enrolled 10 charts
Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy
Completed
10,328 enrolled
Survival Analysis: TACE vs. Combination Therapy in HCC
Completed
279 enrolled
Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
4 enrolled
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Completed
81 enrolled
Muscle Parameters and Pathological Response in Breast Cancer Patients
Completed
69 enrolled
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Completed
1,132 enrolled
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
29 enrolled 8 charts
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
Phase 2 Completed
17 enrolled 5 charts
CAIRO4
Phase 3 Completed
206 enrolled
Evaluation of NanoDoce® in Participants With Urothelial Carcinoma
Phase 1/2 Completed
36 enrolled 18 charts
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
Phase 1 Completed
25 enrolled
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Phase 3 Completed
587 enrolled
SHIP0804
Phase 3 Completed
421 enrolled
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
Phase 2 Completed
80 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
Phase 2 Completed
756 enrolled 12 charts
Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer
Phase NA Completed
154 enrolled
I-ONARC
Completed
317 enrolled
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Completed
1,509 enrolled
"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".
Completed
4 enrolled
NATCH
Phase 3 Completed
624 enrolled
Neoadjuvant Chemotherapy in Cervical Cancer
Phase 3 Completed
33 enrolled
Long Term Bowel Function Following Rectal Cancer Surgery
Phase NA Completed
171 enrolled
Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Phase 3 Completed
93 enrolled
Chemotherapy for Resectable Colorectal Liver Metastases
Completed
967 enrolled
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Phase 2 Completed
15 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
Phase 3 Completed
250 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Phase 3 Completed
350 enrolled
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
Phase 3 Completed
598 enrolled
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
Phase 2 Completed
28 enrolled 7 charts